Forwardly is a public company seeking opportunities to partner in fresh ideas.
We trade on the OTC Market under the symbol FORW.
Read more
FORWARDLY, Inc.
a wholly owned subsidiary of Forwardly, Inc.
Evolutionary. Revolutionary. Just Released – Updated LifeAir™ G1 ventilator prototype.
"Medical Innovation is not just about entrepreneurship, but is also an amazing avenue to save lives and give hope." - Ligand Innovation Global.
LifeAir™ – G1 Ventilator
The LifeAir G1 is a ventilator designed to automate cardiopulmonary resuscitation bags to deliver controlled breaths to patients who have difficulty breathing. Unlike conventional ventilators, the LifeAir is affordable, easy to use, portable – powered by batteries and rechargeable. Conventional ventilators commonly used in intensive care units (ICU) cost $30,000. The LIfeAir will be offered in the low thousands, and is an innovative solution to a severe problem that has truncated the lives of many.
Forwardly, Inc. (OTC:FORW) and Starsona Inc. have executed a Letter of Intent to enable a multi-million dollar investment to be used towards furthering Starsona's growth.
Starsona is a relatively new online platform that allows Celebrities to connect more securely and safely with their fan base, generate additional sources of revenue, and create joy.
LATEST PRESS RELEASE - August 31, 2020
Forwardly, Inc. Raises $500,000 Privately; Will Fund Development of Ligand Innovation Global's Latest Prototype of LifeAir G1
Boulder City, Nevada--(Newsfile Corp. - August 31, 2020) - George Sharp, President and CEO of Forwardly, Inc. (OTC PINK: FORW), announced today that it has already received funding
commitments of $500,000 of an anticipated total of $1.3 million in financing and will itself fund Ligand Innovation Global's ("Ligand") development of its latest prototype of the
LifeAir G1 Portable Ventilator.
As announced in a June 15, 2020 press release, Forwardly, through its wholly owned subsidiary, Breathe Medical Devices, Inc., has obtained the exclusive US distribution rights to the
LifeAir line of ventilator products. As part of the agreement, Forwardly also has the option to acquire up to 25% ownership interest in Ligand. Forwardly's funding of the development
of the new LifeAir G1 prototype will be applied towards the exercise of this option.
READ FULL RELEASE
We found our private funders to be more than eager to participate, by exercising outstanding warrants and purchasing our new series of debentures. I am proud that our private funding sources continue to support our endeavors."
( George Sharp | President • CEO )
“Forwardly is a public company seeking opportunities to partner in fresh ideas.”
The company trades on the OTC Market under the symbol FORW.
Forwardly, Inc.
1022 Nevada Highway
Boulder City, NV 89005